ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) Technical Analysis
NASDAQ:ADAP • US00653A1079
Current stock price
ADAP Technical Rating and Analysis
Overall ADAP gets a technical rating of 0 out of 10. ADAP's overall performance in the market is below average. Also recent evolutions are not that positive. Both the medium and short term picture give negative signs.
- Both the long and short term trends are negative. It is better to avoid buying stocks with negative trends.
- 99% of all other stocks performed better in the past year than ADAP.
- ADAP is part of the Biotechnology industry. There are 516 other stocks in this industry, of which 88% are performing better than ADAP.
- ADAP is currently trading near the lower end of its 52 week range, which is not a good sign. Certainly not because the S&P500 Index is trading near new 52 week highs at the moment.
- In the last month ADAP has a been trading in the 0.04 - 0.28 range, which is quite wide. It is currently trading near the lows of this range.
- Prices have been falling strongly lately, it is better to avoid new long positions here.
- ADAP has an average volume of 124440000 traded shares per day. This is a good sign as it is always nice to have a liquid stock.
ADAP Weekly and Daily overview Charts
ADAP Setup Rating and Analysis
The technical rating of ADAP is bad and it also does not present a quality setup at the moment. Price movement has been a little bit too volatile to find a nice entry and exit point. It is probably a good idea to wait for a consolidation first.
More info and screens
ADAP Support and Resistance Analysis
0.05
We found 1 important support area.
- Support @0.05 from a trend line in the daily time frame.
ADAP Technical Indicator Signal Analysis
The Technical Rating and Setup analysis above combine different indicators and trends in different timeframes. Individual signals from indicators may give more contradictive signals and should always be interpreted in the more global context.
| Indicator | Value | Signal | Comment |
|---|---|---|---|
| ChartMill Long Term Trend Indicator | DOWN | NEGATIVE | The long term trend for ADAP is down. |
| ChartMill Short Term Trend Indicator | DOWN | NEGATIVE | The short term trend for ADAP is down. |
| ChartMill Relative Strength | 1.93 | NEGATIVE | ADAP has a low relative strength, it was outperformed by 98.07% off all stocks on the market. |
| Simple Moving Average/SMA (20) | DOWN | NEGATIVE | The current price of ADAP is below a declining SMA(20). |
| Simple Moving Average/SMA (50) | DOWN | NEGATIVE | The current price of ADAP is below a declining SMA(50). |
| Simple Moving Average/SMA (200) | DOWN | NEGATIVE | The current price of ADAP is below a declining SMA(200). |
| Relative Strength Index/RSI (14) | 38.15 | NEUTRAL | The RSI value for ADAP is a neutral value. |
| Moving Average Convergence Divergence/MACD (12, 26, 9) | -0.02 | NEGATIVE | The MACD value suggests ADAP has a negative trend, although the MACD value is rising. |
| Stochastics (14,3) | 9.22 | OVERSOLD | The low Stochastics value suggests ADAP may be oversold. |
| Average True Range in percent/ATR (20) | 71.12 | HIGH VOLATILITY | The high ATR as a percentage value for ADAP suggests high volalility. |
| Average Directional Index/ADX (14) | 31.64 | POSITIVE | The high ADX value value for ADAP suggests a strong trend. |
ADAP Chart- and CandleStick Pattern Analysis
ADAP Technicals: Chart, Performance Metrics, Trend & Indicators
0.0549
-0.01 (-15.15%)
ADAPTIMMUNE THERAPEUTICS-ADR / ADAP TA FAQ
What is the technical rating for ADAP stock?
ChartMill assigns a technical rating of 0 / 10 to ADAP.
What is the current trend direction of ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) stock?
The current trend direction for ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) is Bearish.
What is the RSI signal for ADAP stock?
ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) has an RSI value of 38.1544. This indicates that the stock is currently neutral.
Can you provide the short term momentum for ADAPTIMMUNE THERAPEUTICS-ADR?
The short term momentum for ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) is negative.
Can you provide the buy/sell signal for ADAPTIMMUNE THERAPEUTICS-ADR?
The buy/sell signal for ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) is sell as both the short term and long term trends are negative.